^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
GC012F
i
Other names: GC012F, GC012, Dual CAR-BCMA-19, BCMA/CD19 dual-target CAR-T cell immunotherapy
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AstraZeneca
Drug class:
CD19-targeted CAR-T immunotherapy, BCMA-targeted CAR-T immunotherapy
Related drugs:
